Poppyred85 "Hundreds of thousands of women take norethisterone as a contraceptive or to manage their heavy periods without "masculinisation" occurring."
Evidently, doctors and the pharmaceutical industry made the same assumption when they rushed the first progestins to market more or less as soon as they could be produced in bulk, and despite warning signs during the clinical trials. Yes, norethisterone is only weakly androgenic in adults, however, if taken during pregnancy, it act as a strong androgen in the foetus. I've attached the first page preview of one of the papers I've found reporting on the phenomenon. Let me quote from it:
"An infrequent but growing clinical literature has accumulated on the occurrence of masculinization of the female fetus in cases of recurrent and threatened abortion treated with ethisterone. Although norethindrone, its 19-nor analog, is of more recent vintage (year of introduction, 1957), its widespread use in obstetrics has been associated with an increased number of published cases of fetal masculinization ... During the course of evaluating the efficiacy of norethindrone in the management of abortion, a clinical trial among 385 consecutive private obstetric patients revealed a high incidence of maternal and fetal virilization. More than 5 per cent of treated women manifested masculinizing side effects, but of greater significance, more than 18 per cent of the female infants born to mothers given this compound during pregnancy manifested some degree of masculinization of the external genitals, viz., clitoral enlargement with or without partial fusion of the labioscrotal folds."
From what it says in that quote (and the fact that some of these drugs were definitely still being given to pregnant women as recently as 1969), there must be a lot of affected people - thousands if not more. Nonetheless, you don't hear anything about it today!
One of the papers I've obtained includes photos of some of the affected babies, and their genitals do look very much like a scrotum and penis. Judging by what the authors of those papers say, nearly all of the affected babies will have been operated on to give them normal-appearing female genitals. Genital appearance was the only concern of the doctors writing up these case reports, however, along with genital masculinization, the hormone-exposed babies will have experienced masculinization of their endocrine system and brain (which the surgery won't have fixed of course).
As to why progestins that are only weakly androgenizing in adults can have strong androgenic effects on female foetuses, I found a paper that talks about the foetal metabolism of hydroxyprogesterone caproate. The foetal liver isn't as good at breaking these compounds down as the adult liver, and as its first stage of trying to get rid of them, it produces metabolites with added hydroxy groups, that are still hormonally active. The parent compounds are all highly lipid soluble and can easily cross the placenta, however these hydroxylated metabolites are less lipid soluble and don't cross the placenta so easily. As a result, you can end up with hormonally active compounds building up to a considerably higher level in the foetal bloodstream than there are in the mother's bloodstream. An added problem with the early testosterone-derived progestins is that some of the metabolites might be much stronger androgens than the parent progestin.